Why the study?
Does the ERS risk score prospectively predict the need for permanent pacemaker implantation in patients undergoing TAVR with a balloon-expandable prosthesis?
Does the ERS risk score prospectively predict the need for permanent pacemaker implantation in patients undergoing TAVR with a balloon-expandable prosthesis?
Answers are grounded in this paper and cite their sources.
The ERS risk score is prospectively validated as a useful framework for preprocedural risk stratification for permanent pacemaker implantation after TAVR with a balloon-expandable prosthesis.
The ERS prospectively predicted the need for PPM in a serial, real-world cohort of patients undergoing TAVR with a balloon-expandable prosthesis, confirming findings previously described in retrospective cohorts. Notably, the prospective performance of the score was comparable with that of the initial cohorts. The risk score could serve as a framework for preprocedural risk stratification for PPM after TAVR.
No takes yet. Share an insight, caveat, or question.
Black et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: